Targeted Therapy
Approved for: NSCLC
Biomarker: KRAS G12C
Sotorasib is the first treatment for adult patients with non–small cell lung cancer whose tumors harbor KRAS G12C mutations and who have received at least 1 prior systemic therapy.
FDA-Approved Lung Cancer Treatments
Sotorasib
I want to give in honor of...
name or relation
Donation Amount
other amount